G Ian Gallicano
Overview
Explore the profile of G Ian Gallicano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
886
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallicano G, Fu J, Mahapatra S, Sharma M, Dillon C, Deng C, et al.
Pharmaceuticals (Basel)
. 2022 Jul;
15(7).
PMID: 35890169
Causes and treatments for heart failure (HF) have been investigated for over a century culminating in data that have led to numerous pharmacological and surgical therapies. Unfortunately, to date, even...
2.
Mahapatra S, Sharma M, Brownson B, Gallicano V, Gallicano G
Mol Biol Cell
. 2022 Jun;
33(11):ar96.
PMID: 35653297
Myocardial fibrosis (MF), a common event that develops after myocardial infarction, initially is a reparative process but eventually leads to heart failure and sudden cardiac arrest. In MF, the infarct...
3.
Lu C, Mahajan A, Hong S, Galli S, Zhu S, Tilan J, et al.
Nat Commun
. 2022 May;
13(1):2729.
PMID: 35550518
No abstract available.
4.
Lu C, Mahajan A, Hong S, Galli S, Zhu S, Tilan J, et al.
Nat Commun
. 2022 Apr;
13(1):2323.
PMID: 35484119
Adverse prognosis in Ewing sarcoma (ES) is associated with the presence of metastases, particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic link between these factors remains...
5.
Abualsaud N, Caprio L, Galli S, Krawczyk E, Alamri L, Zhu S, et al.
Front Cell Dev Biol
. 2021 Mar;
8:627090.
PMID: 33681186
Neuropeptide Y (NPY) has been implicated in the regulation of cellular motility under various physiological and pathological conditions, including cancer dissemination. Yet, the exact signaling pathways leading to these effects...
6.
Gallicano G, Casey J, Fu J, Mahapatra S
Gene Ther
. 2020 Nov;
29(5):304-311.
PMID: 33184504
Covid-19 (SARS CoV-2) has become a deadly, world-wide pandemic. Although most who are infected survive, complications from the virus can be pronounced and long-lasting. To date, of all the respiratory...
7.
Cacciapuoti M, Johnson B, Kapdia A, Powell S, Gallicano G
Stem Cells Dev
. 2020 Aug;
29(19):1266-1274.
PMID: 32731805
Coronary artery disease, including myocardial infarction (MI), is a leading cause of morbidity and mortality in the United States. Due to the limited self-renewal capacity of cardiac tissue, MIs can...
8.
Gallicano G
J Stem Cells Regen Med
. 2019 Jan;
14(2):87.
PMID: 30679894
Stem cell research for treating or curing ischemic heart disease has, to date, culminated in identifying which scenario is more important; 1) stem cell differentiation into cardiomyocytes that integrate electrically...
9.
Mahapatra S, Martin D, Gallicano G
J Stem Cells Regen Med
. 2018 Jul;
14(1):10-26.
PMID: 30018469
Stem cell research for treating or curing ischemic heart disease has, till date, culminated in three basic approaches: the use of induced pluripotent stem cell (iPSC) technology; reprogramming cardiac fibroblasts;...
10.
Zhang Z, Ursin R, Mahapatra S, Gallicano G
Mech Dev
. 2018 Feb;
150:10-20.
PMID: 29427756
Although it is well understood that genetic mutations, chromosomal abnormalities, and epigenetic miscues can cause congenital birth defects, many defects are still labeled idiopathic, meaning their origin is not yet...